Form 4 for EOLS Evolus, Inc.
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-07 · accession 0001387131-23-001621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-08 | 2023-02-07 | EOLS | Medytox Inc. | 10% | S - Sale | $8.50 | -2.19M | 5.07M | -30% | -$18.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.00001 par value per share | 2023-02-07 | S | D | 2,187,511 | $8.50 | 5,071,989 | D | — | — |